000 02442nam  2200349zi 4500
0019.894084
003CaOODSP
00520240209131719
006m     o  d f      
007cr cn|||||||||
008201126t20202020onc     o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-24/2020-44E-PDF
24500|aPydiflumetofen.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2020.
264 4|c©2020
300 |a1 online resource (6 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed maximum residue limit, |x1925-0843 ; |vPMRL2020-44
500 |aIssued also in French under title: Pydiflumétofène.
500 |a"25 November 2020."
500 |aCover title.
520 |a"Under the authority of the Pest Control Products Act, Health Canada’s Pest Management Regulatory Agency (PMRA) has concluded that the addition of new uses on various commodities to the product labels of A19649 Fungicide, containing pydiflumetofen, MIRAVIS Neo Fungicide, containing pydiflumetofen, azoxystrobin and propiconazole, A20560 Fungicide, containing pydiflumetofen and fludioxonil, and A20259 Fungicide, containing pydiflumetofen and difenoconazole, are acceptable. The specific uses approved in Canada are detailed on the labels of A19649 Fungicide (PCP No. 33018), MIRAVIS Neo Fungicide (PCP No. 33022), A20560 Fungicide (PCP No. 33021) and A20259 Fungicide (PCP No. 33020). Consultation on the maximum residue limits (MRLs) for difenoconazole is being conducted under a separate action while relevant MRLs for azoxystrobin, fludioxonil and propiconazole can be found in the Maximum Residue Limit Database. The evaluation of these pydiflumetofen applications indicated that the end-use products have value and the human health and environmental risks associated with their proposed uses are acceptable"--Page 1.
650 0|aFungicides|xCertification|zCanada.
650 0|aPesticide residues in food|xStandards|zCanada.
7101 |aCanada. |bPest Management Regulatory Agency, |eissuing body.
77508|tPydiflumétofène.|w(CaOODSP)9.894086
830#0|aProposed maximum residue limit,|x1925-0843 ; |vPMRL2020-44.|w(CaOODSP)9.505147
85640|qPDF|s204 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/h113-24/H113-24-2020-44-eng.pdf